EP2114418A4 - ORAL DOSAGE FORM WITH STABILIZED PICOPLATIN - Google Patents

ORAL DOSAGE FORM WITH STABILIZED PICOPLATIN

Info

Publication number
EP2114418A4
EP2114418A4 EP08725393A EP08725393A EP2114418A4 EP 2114418 A4 EP2114418 A4 EP 2114418A4 EP 08725393 A EP08725393 A EP 08725393A EP 08725393 A EP08725393 A EP 08725393A EP 2114418 A4 EP2114418 A4 EP 2114418A4
Authority
EP
European Patent Office
Prior art keywords
dosage form
oral dosage
stabilized picoplatin
picoplatin oral
stabilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08725393A
Other languages
German (de)
English (en)
French (fr)
Other versions
EP2114418A1 (en
Inventor
Alistair J Leigh
Christopher A Procyshyn
Ernest S Y Wong
Christen M Giandomenico
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Poniard Pharmaceuticals Inc
Original Assignee
Genzyme Corp
Poniard Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp, Poniard Pharmaceuticals Inc filed Critical Genzyme Corp
Publication of EP2114418A1 publication Critical patent/EP2114418A1/en
Publication of EP2114418A4 publication Critical patent/EP2114418A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/28—Mercury; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP08725393A 2007-02-09 2008-02-08 ORAL DOSAGE FORM WITH STABILIZED PICOPLATIN Withdrawn EP2114418A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88917107P 2007-02-09 2007-02-09
US88968107P 2007-02-13 2007-02-13
PCT/US2008/001752 WO2008097661A1 (en) 2007-02-09 2008-02-08 Stabilized picoplatin oral dosage form

Publications (2)

Publication Number Publication Date
EP2114418A1 EP2114418A1 (en) 2009-11-11
EP2114418A4 true EP2114418A4 (en) 2013-01-09

Family

ID=39682046

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08725393A Withdrawn EP2114418A4 (en) 2007-02-09 2008-02-08 ORAL DOSAGE FORM WITH STABILIZED PICOPLATIN

Country Status (12)

Country Link
EP (1) EP2114418A4 (enExample)
JP (1) JP2010518089A (enExample)
KR (1) KR20090109129A (enExample)
CN (2) CN104288119A (enExample)
AU (1) AU2008214202A1 (enExample)
BR (1) BRPI0806418A2 (enExample)
CA (1) CA2677640A1 (enExample)
HK (1) HK1206267A1 (enExample)
IL (1) IL200262A0 (enExample)
MX (1) MX2009008488A (enExample)
RU (1) RU2009133446A (enExample)
WO (1) WO2008097661A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8168661B2 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8168662B1 (en) 2006-11-06 2012-05-01 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8178564B2 (en) 2006-11-06 2012-05-15 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
US8173686B2 (en) 2006-11-06 2012-05-08 Poniard Pharmaceuticals, Inc. Use of picoplatin to treat colorectal cancer
WO2010120336A1 (en) * 2009-04-15 2010-10-21 Poniard Pharmaceuticals, Inc. High bioavailability oral picoplatin anti-cancer therapy
AU2015263884B2 (en) * 2014-05-23 2019-11-14 Mingsight Pharmaceuticals, Inc. Treatment of autoimmune disease
CN107778331B (zh) * 2016-08-27 2020-06-30 鲁南制药集团股份有限公司 一种甲啶铂的提纯方法
CN108864177B (zh) * 2018-04-20 2020-07-28 公安部物证鉴定中心 [2h3]-1-甲氨基-2-苯基丙烷的合成方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9502799D0 (en) * 1995-02-14 1995-04-05 Johnson Matthey Plc Improvements in platinum complexes
DE60032517T2 (de) * 2000-02-16 2007-10-04 Astellas Pharma Inc. Heilmittel gegen durch endothelin verursachte erkrankungen
JP2004529929A (ja) * 2001-04-23 2004-09-30 ニュクリスト ファーマシューティカルズ コーポレーション アポトーシスの誘導およびマトリックスメタロプロテイナーゼの阻害のための金属の使用
DE10141528B4 (de) * 2001-08-24 2006-08-10 Faustus Forschungs Cie. Translational Cancer Research Gmbh Platin(II)- und Platin(IV)-Komplexe und ihre Verwendung
US20050119238A1 (en) * 2002-03-01 2005-06-02 Baron John A. Compositions and methods for preventing sporadic neoplasia in colon
WO2004006859A2 (en) * 2002-07-16 2004-01-22 Sonus Pharmaceuticals, Inc. Platinum compound
US20040101553A1 (en) * 2002-08-02 2004-05-27 Transave, Inc. Platinum aggregates and process for producing the same
US20050249822A1 (en) * 2004-03-18 2005-11-10 Transave, Inc. Administration of cisplatin by inhalation
US20060205810A1 (en) * 2004-11-24 2006-09-14 Schering Corporation Platinum therapeutic combinations

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *

Also Published As

Publication number Publication date
IL200262A0 (en) 2010-04-29
MX2009008488A (es) 2010-01-15
KR20090109129A (ko) 2009-10-19
JP2010518089A (ja) 2010-05-27
RU2009133446A (ru) 2011-03-20
HK1206267A1 (en) 2016-01-08
CA2677640A1 (en) 2008-08-14
AU2008214202A1 (en) 2008-08-14
CN104288119A (zh) 2015-01-21
WO2008097661A1 (en) 2008-08-14
EP2114418A1 (en) 2009-11-11
BRPI0806418A2 (pt) 2011-09-06
CN101678046A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
IL251175A0 (en) Stabilized dosage of picoplatin
IL206159A0 (en) Oral pharmaceutical dosage forms
EP2178893A4 (en) ORAL FORMULATIONS FOR PICOPLATIN
ZA201006029B (en) Pharmaceutical dosage form
AP2010005341A0 (en) Solid pharmaceutical dosage form
IL211028A0 (en) Linaclotide-containing formulations for oral administration
PL2077729T3 (pl) Doustne postacie dawkowania probiotyku
GB0710439D0 (en) Oral dosage form
PL2167033T4 (pl) Podawana raz dziennie doustna postać dawkowania zawierająca takrolimus
IL205160A0 (en) Oral dosage forms comprising licarbazepine acetate
ZA201100615B (en) Appetising medicament for oral administration in solid form
EP2226071A4 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
IL194366A0 (en) Solid dosage formulations
ZA200903858B (en) Pharmaceutical dosage form
IL200619A0 (en) Novel dosage form
EP2114418A4 (en) ORAL DOSAGE FORM WITH STABILIZED PICOPLATIN
GB0616794D0 (en) Solid dosage form
GB0822124D0 (en) Oral dosage form
EP2337565A4 (en) STABLE SOLID ORAL CO DOSAGE FORMULATIONS
ZA201102405B (en) Pharmaceutical composition for oral administration
GB0704123D0 (en) Dosage form
GB0723310D0 (en) Solid dosage vaccine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20090908

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20121211

RIC1 Information provided on ipc code assigned before grant

Ipc: A01N 55/02 20060101ALI20121205BHEP

Ipc: A61K 33/24 20060101AFI20121205BHEP

Ipc: A61K 9/28 20060101ALI20121205BHEP

Ipc: A61K 31/28 20060101ALI20121205BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20130905